Koers BioLight Life Sciences Ltd TEL AVIV STOCK EXCHANGE
Aandelen
IL0010952237
Geavanceerde medische apparatuur & technologie
Omzet 2022 | 63K 17,12K 6,3 mln. 15,8K | Omzet 2023 | 118K 32,06K 11,8 mln. 29,59K | Marktkapitalisatie | 24,12 mln. 6,55 mln. 2,41 mld. 6,05 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -7 mln. -1,9 mln. -700 mln. -1,76 mln. | Nettowinst (verlies) 2023 | -26 mln. -7,06 mln. -2,6 mld. -6,52 mln. | EV/omzet 2022 | 207 x |
Nettoliquiditeiten 2022 | 17,1 mln. 4,65 mln. 1,71 mld. 4,29 mln. | Nettoliquiditeiten 2023 | 8,55 mln. 2,32 mln. 855 mln. 2,14 mln. | EV/omzet 2023 | 132 x |
K/w-verhouding 2022 |
-3,85
x | K/w-verhouding 2023 |
-0,93
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 43,16% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 54 | 01-05-20 | |
Yifftach Biel
DFI | Director of Finance/CFO | 48 | 01-05-15 |
Ron Neumann
CTO | Chief Tech/Sci/R&D Officer | 69 | 01-12-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Israel Makov
CHM | Chairman | 85 | 21-04-11 |
Kobi Faigenbaum
BRD | Director/Board Member | 71 | 11-05-17 |
Alla Felder
BRD | Director/Board Member | 50 | 25-03-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,18% | 225 mld. | |
+15,22% | 197 mld. | |
+19,19% | 143 mld. | |
+30,89% | 111 mld. | |
+2,74% | 64,72 mld. | |
+18,48% | 54,44 mld. | |
+5,12% | 51,06 mld. | |
+10,53% | 45,03 mld. | |
+5,98% | 37,4 mld. |